KRT76
gene geneOn this page
Also known as HUMCYT2AKRT2BKRT2P
Summary
KRT76 (keratin 76, HGNC:24430) is a protein-coding gene on chromosome 12q13.13, encoding Keratin, type II cytoskeletal 2 oral (Q01546). Probably contributes to terminal cornification.
Keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into epithelial keratins and hair keratins. The type II keratins are clustered in a region of chromosome 12q13.
Source: NCBI Gene 51350 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 115 total
- MANE Select transcript:
NM_015848
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24430 |
| Approved symbol | KRT76 |
| Name | keratin 76 |
| Location | 12q13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HUMCYT2A, KRT2B, KRT2P |
| Ensembl gene | ENSG00000185069 |
| Ensembl biotype | protein_coding |
| OMIM | 616671 |
| Entrez | 51350 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000332411
RefSeq mRNA: 1 — MANE Select: NM_015848
NM_015848
CCDS: CCDS8838
Canonical transcript exons
ENST00000332411 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001290056 | 52775388 | 52775602 |
| ENSE00001294138 | 52768155 | 52769110 |
| ENSE00001319852 | 52776692 | 52777345 |
| ENSE00001321931 | 52772783 | 52772878 |
| ENSE00001323177 | 52771871 | 52771996 |
| ENSE00001620158 | 52769549 | 52769583 |
| ENSE00001650813 | 52770999 | 52771219 |
| ENSE00001679279 | 52772094 | 52772258 |
| ENSE00001681343 | 52773582 | 52773642 |
Expression profiles
Bgee: expression breadth broad, 24 present calls, max score 95.98.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2151 / max 203.9119, expressed in 6 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 131123 | 0.2151 | 6 |
Top tissues by expression
261 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gingiva | UBERON:0001828 | 95.98 | gold quality |
| gingival epithelium | UBERON:0001949 | 94.71 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 93.91 | gold quality |
| tongue | UBERON:0001723 | 78.89 | gold quality |
| body of tongue | UBERON:0011876 | 76.61 | gold quality |
| superior surface of tongue | UBERON:0007371 | 70.34 | gold quality |
| cervix epithelium | UBERON:0004801 | 61.85 | silver quality |
| olfactory bulb | UBERON:0002264 | 61.83 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 60.55 | gold quality |
| diaphragm | UBERON:0001103 | 59.60 | gold quality |
| nephron tubule | UBERON:0001231 | 58.55 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 58.06 | gold quality |
| squamous epithelium | UBERON:0006914 | 57.54 | gold quality |
| oviduct epithelium | UBERON:0004804 | 55.42 | silver quality |
| kidney epithelium | UBERON:0004819 | 53.36 | gold quality |
| vastus lateralis | UBERON:0001379 | 52.78 | gold quality |
| quadriceps femoris | UBERON:0001377 | 52.56 | gold quality |
| buccal mucosa cell | CL:0002336 | 52.31 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 50.98 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 48.98 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| tonsil | UBERON:0002372 | 48.55 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 17.69 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting KRT76, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
| HSA-MIR-301B-3P | 99.90 | 73.19 | 1836 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-3666 | 99.90 | 73.24 | 1833 |
| HSA-MIR-4295 | 99.90 | 73.11 | 1838 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-148A-3P | 99.74 | 73.77 | 1700 |
| HSA-MIR-148B-3P | 99.74 | 73.75 | 1700 |
| HSA-MIR-152-3P | 99.74 | 73.75 | 1703 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-1224-5P | 99.48 | 65.59 | 803 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
| HSA-MIR-4786-3P | 99.36 | 68.35 | 1390 |
| HSA-MIR-4292 | 99.16 | 65.57 | 1767 |
| HSA-MIR-6791-5P | 99.16 | 65.92 | 1844 |
| HSA-MIR-6876-3P | 98.97 | 65.69 | 765 |
| HSA-MIR-626 | 98.89 | 66.21 | 762 |
| HSA-MIR-876-3P | 98.76 | 68.23 | 945 |
| HSA-MIR-4290 | 98.51 | 65.17 | 907 |
| HSA-MIR-4518 | 98.12 | 66.82 | 1030 |
| HSA-MIR-6511B-5P | 97.98 | 65.64 | 823 |
| HSA-MIR-6811-5P | 97.98 | 64.96 | 848 |
| HSA-MIR-7113-5P | 97.88 | 67.33 | 1735 |
| HSA-MIR-1266-5P | 97.71 | 66.92 | 1052 |
Literature-anchored findings (GeneRIF, showing 2)
- Data shows that immunomodulatory role of Keratin 76 in oral and gastric cancer. (PMID:30143634)
- K2P2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathies. (PMID:37935063)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krt76 | ENSMUSG00000075402 |
| rattus_norvegicus | Krt76 | ENSRNOG00000031785 |
Paralogs (68): KRT33A (ENSG00000006059), VIM (ENSG00000026025), KRT31 (ENSG00000094796), NEFM (ENSG00000104722), KRT23 (ENSG00000108244), KRT37 (ENSG00000108417), KRT32 (ENSG00000108759), KRT18 (ENSG00000111057), LMNB1 (ENSG00000113368), KRT36 (ENSG00000126337), KRT17 (ENSG00000128422), GFAP (ENSG00000131095), KRT34 (ENSG00000131737), KRT33B (ENSG00000131738), NES (ENSG00000132688), PRPH (ENSG00000135406), KRT85 (ENSG00000135443), KRT7 (ENSG00000135480), KRT71 (ENSG00000139648), INA (ENSG00000148798), LMNTD1 (ENSG00000152936), LMNA (ENSG00000160789), KRT84 (ENSG00000161849), KRT82 (ENSG00000161850), KRT80 (ENSG00000167767), KRT1 (ENSG00000167768), KRT24 (ENSG00000167916), KRT8 (ENSG00000170421), KRT78 (ENSG00000170423), KRT86 (ENSG00000170442), KRT75 (ENSG00000170454), KRT6C (ENSG00000170465), KRT4 (ENSG00000170477), KRT74 (ENSG00000170484), KRT72 (ENSG00000170486), KRT83 (ENSG00000170523), BFSP2 (ENSG00000170819), KRT19 (ENSG00000171345), KRT15 (ENSG00000171346), KRT38 (ENSG00000171360)
Protein
Protein identifiers
Keratin, type II cytoskeletal 2 oral — Q01546 (reviewed: Q01546)
Alternative names: Cytokeratin-2P, Keratin-76, Type-II keratin Kb9
All UniProt accessions (1): Q01546
UniProt curated annotations — full annotation on UniProt →
Function. Probably contributes to terminal cornification.
Subunit / interactions. Heterotetramer of two type I and two type II keratins.
Miscellaneous. There are two types of cytoskeletal and microfibrillar keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).
Similarity. Belongs to the intermediate filament family.
RefSeq proteins (1): NP_056932* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003054 | Keratin_II | Family |
| IPR018039 | IF_conserved | Conserved_site |
| IPR032444 | Keratin_2_head | Domain |
| IPR039008 | IF_rod_dom | Domain |
Pfam: PF00038, PF16208
UniProt features (24 total): region of interest 8, compositionally biased region 6, sequence variant 4, modified residue 3, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q01546-F1 | 65.30 | 0.37 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 85, 110, 584
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 77 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS, GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION, PUJANA_CHEK2_PCC_NETWORK, GOBP_PIGMENTATION, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, MODULE_99, GOBP_EPIDERMIS_DEVELOPMENT, MODULE_113, GOBP_KERATINIZATION, GOBP_SKIN_DEVELOPMENT, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT
GO Biological Process (6): cytoskeleton organization (GO:0007010), keratinization (GO:0031424), pigmentation (GO:0043473), intermediate filament organization (GO:0045109), sebaceous gland development (GO:0048733), epidermis development (GO:0008544)
GO Molecular Function (2): structural constituent of skin epidermis (GO:0030280), protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), cytosol (GO:0005829), intermediate filament (GO:0005882), keratin filament (GO:0045095), extracellular exosome (GO:0070062)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
| Keratinization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| organelle organization | 1 |
| keratinocyte differentiation | 1 |
| multicellular organismal process | 1 |
| biological_process | 1 |
| intermediate filament cytoskeleton organization | 1 |
| supramolecular fiber organization | 1 |
| skin development | 1 |
| gland development | 1 |
| tissue development | 1 |
| structural molecule activity | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
| intermediate filament | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
1349 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRT76 | KCNK18 | Q7Z418 | 987 |
| KRT76 | KCNK6 | Q9Y257 | 980 |
| KRT76 | KCNK1 | O00180 | 975 |
| KRT76 | KCNK7 | Q9Y2U2 | 952 |
| KRT76 | KCNK2 | O95069 | 903 |
| KRT76 | MT-CO1 | P00395 | 888 |
| KRT76 | KCNK10 | P57789 | 883 |
| KRT76 | KCNK4 | Q9NYG8 | 883 |
| KRT76 | KCNK9 | Q9NPC2 | 880 |
| KRT76 | KCNK3 | O14649 | 878 |
| KRT76 | KCNK5 | O95279 | 799 |
| KRT76 | CSN3 | P07498 | 722 |
| KRT76 | KCNK17 | Q96T54 | 720 |
| KRT76 | KCNK16 | Q96T55 | 720 |
| KRT76 | KCNK13 | Q9HB14 | 716 |
| KRT76 | MT-CYB | P00156 | 716 |
IntAct
140 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRT76 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.630 |
| KRT31 | KRT76 | psi-mi:“MI:0915”(physical association) | 0.630 |
| TRIM27 | KRT76 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | NFKBID | psi-mi:“MI:0915”(physical association) | 0.560 |
| HGS | KRT76 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | CCDC57 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | TRIM54 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | IQUB | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | IPO11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT37 | KRT76 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | DPPA3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | TSGA10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | MID2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POLR1C | KRT76 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | C1orf216 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FRS3 | KRT76 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | KRT27 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | KRT39 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | CDC37 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | KRT25 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMO4 | KRT76 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT75 | KRT76 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | EXOC8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | CFAP206 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | AIRIM | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT36 | KRT76 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | RSPH14 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | FOXR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT76 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (89): KRT76 (Affinity Capture-MS), KRT76 (Affinity Capture-MS), KRT76 (Affinity Capture-MS), KRT76 (Two-hybrid), KRT76 (Two-hybrid), KRT76 (Two-hybrid), KRT76 (Two-hybrid), KRT76 (Two-hybrid), KRT76 (Two-hybrid), KRT76 (Two-hybrid), KRT76 (Two-hybrid), KRT76 (Two-hybrid), KRT76 (Two-hybrid), KRT76 (Two-hybrid), KRT76 (Two-hybrid)
ESM2 similar proteins: A5A6M6, A5A6M8, O95678, P02535, P02537, P02538, P04104, P04259, P04264, P06394, P07744, P08776, P12035, P13645, P13647, P16878, P18520, P19013, P35527, P35908, P48668, P50446, Q01546, Q08D91, Q148H7, Q29426, Q2M2I5, Q3TTY5, Q3UV17, Q4FZU2, Q5XQN5, Q6EIY9, Q6EIZ0, Q6EIZ1, Q6IFW6, Q6IFZ6, Q6IG00, Q6IG01, Q6IG02, Q6IG05
Diamond homologs: A0A125S9M6, A0JND2, A4FUZ0, A5A6M8, A6NCN2, A7YWK3, O43790, P02542, P02545, P02547, P02548, P04104, P04260, P04261, P04262, P04263, P07196, P07744, P08551, P08928, P09010, P10999, P12035, P12036, P13647, P13648, P15241, P16884, P19013, P19246, P19527, P21619, P21910, P25691, P35908, P48671, P48672, P48678, P48679, P78385
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 63 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Formation of the cornified envelope | 12 | 28.5× | 9e-13 |
| Keratinization | 12 | 18.1× | 1e-10 |
| Neddylation | 8 | 10.2× | 6e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| morphogenesis of an epithelium | 10 | 61.4× | 9e-14 |
| intermediate filament organization | 12 | 51.6× | 2e-15 |
| epithelial cell differentiation | 9 | 28.2× | 3e-09 |
| G1/S transition of mitotic cell cycle | 5 | 17.9× | 6e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
115 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 102 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1196 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:52769547:A:AC | donor_gain | 1.0000 |
| 12:52769548:C:CC | donor_gain | 1.0000 |
| 12:52770993:CCTCA:C | donor_loss | 1.0000 |
| 12:52770994:CTCA:C | donor_loss | 1.0000 |
| 12:52770997:A:T | donor_loss | 1.0000 |
| 12:52770998:C:CA | donor_loss | 1.0000 |
| 12:52771011:C:CA | donor_gain | 1.0000 |
| 12:52771215:GCATT:G | acceptor_gain | 1.0000 |
| 12:52771216:CATT:C | acceptor_gain | 1.0000 |
| 12:52771216:CATTC:C | acceptor_gain | 1.0000 |
| 12:52771217:ATT:A | acceptor_gain | 1.0000 |
| 12:52771218:TT:T | acceptor_gain | 1.0000 |
| 12:52771220:C:CC | acceptor_gain | 1.0000 |
| 12:52771225:G:C | acceptor_gain | 1.0000 |
| 12:52771225:G:GC | acceptor_gain | 1.0000 |
| 12:52771902:AG:A | donor_gain | 1.0000 |
| 12:52772088:TCCCA:T | donor_loss | 1.0000 |
| 12:52772089:CCCAC:C | donor_loss | 1.0000 |
| 12:52772090:CCACC:C | donor_loss | 1.0000 |
| 12:52772091:CACCT:C | donor_loss | 1.0000 |
| 12:52772092:A:T | donor_loss | 1.0000 |
| 12:52772093:C:CG | donor_loss | 1.0000 |
| 12:52772116:G:C | donor_gain | 1.0000 |
| 12:52772254:AGCTC:A | acceptor_gain | 1.0000 |
| 12:52772256:CTC:C | acceptor_gain | 1.0000 |
| 12:52772257:TC:T | acceptor_gain | 1.0000 |
| 12:52772257:TCC:T | acceptor_loss | 1.0000 |
| 12:52772258:CC:C | acceptor_gain | 1.0000 |
| 12:52772258:CCT:C | acceptor_loss | 1.0000 |
| 12:52772259:C:CC | acceptor_gain | 1.0000 |
AlphaMissense
4235 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:52773619:C:G | R280P | 0.995 |
| 12:52773585:C:A | K291N | 0.993 |
| 12:52773585:C:G | K291N | 0.993 |
| 12:52771923:A:G | L404P | 0.991 |
| 12:52771953:A:G | L394P | 0.991 |
| 12:52771902:A:G | L411P | 0.990 |
| 12:52772117:C:G | A372P | 0.988 |
| 12:52773620:G:T | R280S | 0.988 |
| 12:52773597:A:C | F287L | 0.986 |
| 12:52773597:A:T | F287L | 0.986 |
| 12:52773599:A:G | F287L | 0.986 |
| 12:52772844:A:G | L304P | 0.985 |
| 12:52773611:C:G | A283P | 0.982 |
| 12:52776710:A:C | F194L | 0.982 |
| 12:52776710:A:T | F194L | 0.982 |
| 12:52776712:A:G | F194L | 0.982 |
| 12:52771071:A:G | L471P | 0.979 |
| 12:52771986:A:G | L383P | 0.979 |
| 12:52771020:A:G | L488P | 0.972 |
| 12:52771156:C:G | A443P | 0.972 |
| 12:52771189:C:G | A432P | 0.972 |
| 12:52771026:C:G | R486P | 0.971 |
| 12:52771058:C:A | K475N | 0.971 |
| 12:52771058:C:G | K475N | 0.971 |
| 12:52772804:G:C | F317L | 0.971 |
| 12:52772804:G:T | F317L | 0.971 |
| 12:52772806:A:G | F317L | 0.971 |
| 12:52771036:C:G | A483P | 0.967 |
| 12:52772872:C:G | D295H | 0.966 |
| 12:52773586:T:G | K291T | 0.966 |
dbSNP variants (sampled 300 via entrez): RS1000072395 (12:52776846 C>T), RS1000087726 (12:52770480 A>C,G), RS1001286085 (12:52774693 C>A,G), RS1001367305 (12:52776209 C>G), RS1001612626 (12:52771431 C>G,T), RS1002069329 (12:52770528 G>A), RS1002125826 (12:52771748 C>G,T), RS1002393494 (12:52775721 T>A,C), RS1002496698 (12:52778340 A>G), RS1003020712 (12:52772568 C>T), RS1003204255 (12:52778793 G>A), RS1003360202 (12:52773468 C>A), RS1003433630 (12:52772993 G>A), RS1003875313 (12:52778995 C>T), RS1004711257 (12:52778551 T>G)
Disease associations
OMIM: gene MIM:616671 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | affects expression, decreases expression | 2 |
| beauvericin | affects cotreatment, decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| enniatins | affects cotreatment, decreases expression | 1 |
| corosolic acid | increases expression | 1 |
| Aerosols | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Dinitrochlorobenzene | affects binding | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.